Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. [electronic resource]
Producer: 20190916Description: 1936-1943 p. digitalISSN:- 1532-2092
- Aged
- Anticoagulants -- adverse effects
- Atrial Fibrillation -- diagnosis
- Cost Savings
- Cost-Benefit Analysis
- Drug Costs
- Echocardiography, Transesophageal
- Electric Countershock -- adverse effects
- Emergency Service, Hospital
- Europe
- Factor Xa Inhibitors -- adverse effects
- Female
- Hemorrhage -- chemically induced
- Hospital Costs
- Humans
- Male
- Middle Aged
- Patient Readmission
- Patient Satisfaction
- Pyridines -- adverse effects
- Risk Factors
- Thiazoles -- adverse effects
- Time Factors
- Treatment Outcome
- United States
- Warfarin -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.